Dr Kathy Flitcroft PhD
Research Fellow/Research Manager
Dr Kathy Flitcroft PhD
Kathy is the BSO’s Research Fellow, with an active research profile. She is an experienced qualitative health and health policy researcher with a PhD in public health, a master’s degree in government, a graduate certificate in health policy, an undergraduate degree in behavioural sciences and registered nurse qualifications. Kathy’s main research interest is the translation of evidence into cancer policy and practice, and all her publications deal with some aspect of evidence translation. Kathy is passionate about facilitating informed choice for patients, particularly in relation to options for breast reconstruction.
Kathy’s major project over the last few years is titled Improving Breast Reconstruction Equity of Access through Stakeholder consultation and Translation into policy and practice (I-BREAST). The final stage of this project, which will be completed in 2019, involves a series of roundtable meetings with a full range of stakeholders – women with breast cancer, general surgeons, breast surgeons, plastic reconstructive surgeons, oncology clinicians, breast care nurses, hospital administrators, local area health, state/territory and federal health department representatives and policy makers – to discuss possible policy and practice changes to current models of care.
Kathy also has a research manager role with BSO where she oversees the breast cancer research conducted within the practice. This involves working with surgical breast fellows, the clinical trials manager and our practice surgeons to support a range of research initiatives including a survey of postgraduate surgical fellows undertaking further training in oncoplastic techniques. During 2018/19 she has been involved in projects with research collaborators from the United Kingdom and Canada, as well as Sydney University.
Kathy can be contacted on
- Oh D, Flitcroft K, Meagan E Brennan, Kylie Snook, Andrew J. Spillane. Outcomes of breast reconstruction in older women: Patterns of uptake and clinical outcomes in a large metropolitan practice. (Accepted ANZJS 12 Feb 2019).
- Flitcroft KL, Brennan ME, Spillane AJ. The impact on Australian women of lack of choice of breast reconstruction options: A qualitative study. Psycho-oncology 2019;1–6. https://doi.org/10.1002/pon.4974 (Early on line version, 23 Jan 2019).
- Azimi F, Flitcroft K, Mathieu E, Karantonis R, Snook K, Spillane A. Low level laser treatment is ineffective for capsular contracture. Results of the LaTCon randomised controlled trial. Plast Reconstr Surg 2018; 142: 621e-31e.
- Oh DD, Flitcroft K, Brennan ME, Snook K, Spillane AJ. Outcomes of breast reconstruction in older women: Patterns of uptake andclinical outcomes in a large metropolitan practice. (under review)
- Azimi F, Flitcroft K, Mathieu E, Karantonis R, Snook K, Spillane A. Low level laser treatment is ineffective for capsular contracture. Results of the LaTCon randomised controlled trial. [Accepted December 2017, Plastic & Reconstructive Surgery].
- Flitcroft K, Brennan M, Costa D, Spillane A. Regional variation in immediate breast reconstruction rates in Australia. BJS Open, 2017. 1: 114–121. DOI: 10.1002/bjs5.19
- Flitcroft K, Brennan M, Spillane A. Women’s expectations of breast reconstruction following mastectomy for breast cancer. A systematic review. Support Care Cancer. 2017 Aug;25(8):2631-2661.
- Flitcroft K, Brennan M, Spillane A. Making decisions about breast reconstruction: A systematic review of patient-reported factors influencing choice. Qual Life Res. 2017 Sep;26(9):2287-2319.
- Brennan ME, Flitcroft K, Warrier S, Snook K, Spillane AJ. Immediate expander/implant breast reconstruction followed by post-mastectomy radiotherapy for breast cancer: Aesthetic, surgical, satisfaction and quality of life outcomes in women with high-risk breast cancer. The Breast 2016;30:59–65. Abstract
- Flitcroft K, Brennan M, Costa D, Spillane A. Documenting patterns of access to breast reconstruction in Australia: The National Picture. The Breast 2016; 30: 47-53. Abstract
- Flitcroft K, Brennan M, Costa D, Wong A, Snook K and Spillane A. An evaluation of factors affecting preference for immediate, delayed or no breast reconstruction in women with high-risk breast cancer. Psycho-oncology 2016; 25(12):1463-1469. Abstract
- Flitcroft K, Brennan M, Spillane A. The difficulties of sourcing Australian health data: The case of breast reconstruction. ANZ Journal of Surgery, 2016 Jul;86(7-8):537-9. Link to journal
- Oh DD, Flitcroft K, Brennan ME, Spillane AJ. Patterns and outcomes of breast reconstruction in older women – a systematic review of the literature. EJSO 2016;42(5):604-615. Abstract
- Winters Z, Azfal M, Rumpold G, Holzner B, Oberguggenburger A, Da Costa Vieira R, Hartnup S, Flitcroft K, Bjelic-Radisic V, Panouilleres M, Rydevik-Mani M, King M, Rutherford C. International validation of the EORTC Patient-Reported Outcome Measure (PROM) in breast reconstruction (BRR): Evaluating health related quality of life (HRQL) and clinical effectiveness. Eur J Surg Oncol 2016. DoI: http://dx.doi.org/10.1016.ejso.2016.02.042 Abstract
- Wortley S, Flitcroft K, Howard, K. The role of preference information in health technology assessment decision-making. International Journal of Technology Assessment in Health Care 2015;31(4):241-248.
- Read R, Flitcroft K, Snook K, Boyle F, Spillane A. The utility of neoadjuvant chemotherapy in the treatment of operable breast cancer. ANZ Journal of Surgery. 2015;85(5):315-20. Abstract
- Brennan ME, Spillane A, Flitcroft K, Snook K, Wong A. Platinum multidisciplinary breast cancer care or platinum breast reconstruction? ANZJS 2014;84(9):604-605. Journal
- Flitcroft KL, Spillane AJ, Read RL. Lack of appropriate imaging before breast augmentation can have serious patient consequences. Med J Aust. 2014 Mar 3;200(4):198-9. Journal
- Wong A, Snook K, Brennan M, Flitcroft K, Tucker M, Hiercz D,Spillane A. Increasing breast reconstruction rates by offering more women a choice. ANZ Journal of Surgery 2014;84:31-36. Journal
- Flitcroft KL, Gillespie JA, Carter SM, Salkeld GP, Trevena LJ. Incorporating evidence and politics in health policy: Can institutionalising evidence review make a difference? Evidence & Policy: 29 November 2013.Abstract
- Flitcroft KL, Irwig LM, Carter SM, Salkeld GP, Gillespie JA. Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option. BMC Gastroenterology 2012;12: e183.
- Flitcroft KL, St John DJ, Howard K, Carter SM, Pignone MP, Salkeld GP, Trevena LJ. A case study of bowel cancer screening in the UK and Australia: Evidence lost in translation? Journal of Medical Screening 2011;18: 193-203.
- Flitcroft KL, Gillespie JA, Carter SM, Trevena LJ, Salkeld GP. When good evidence is not enough: the role of context in bowel cancer screening policy in New Zealand. Evidence & Policy 2011; 7(3): 307-26. Abstract
- Pignone M, Flitcroft KL, Howard K, Trevena LJ, Salkeld GP, St John, DJ. Costs and cost-effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer in Australia. Medical Journal of Australia 2011; 194(4): 180-185.Free full text pdf
- Flitcroft KL, Gillespie JA, Carter SM, Salkeld GP, Trevena LJ, Getting research into policy: the need for deliberative strategies? Social Science & Medicine 2011; 72: 1039-1046. Abstract
- Flitcroft KL, Salkeld GP, Gillespie JA, Trevena LJ, Irwig LM. Fifteen years of bowel cancer screening policy in Australia: putting evidence into practice? Medical Journal of Australia, 193 (1); 5 July 2010: 37-42. Abstract
- Entwistle VA, Carter SM, Trevena LJ, Flitcroft KL, Irwig LM, McCaffery K, Salkeld GP. Communicating about screening: a proposed new direction. British Medical Journal, 337; 4 October 2008: 789-791.[No abstract] Journal
- Boxall AM, Flitcroft KL. From little things, big things grow: A local approach to system-wide maternity services reform in the absence of definitive evidence. Australia and New Zealand Health Policy 2007, 4:18.
- Flitcroft KL, Boxall AM. Maternity services options: A review of the evidence on alternative models of care. Commissioned report for Sydney South West Area Health Service, Australian Health Policy Institute, 2006.
- Flitcroft K, Brennan M, Spillane A. Health system barriers to the discussion of breast reconstruction options in Australia: Improving informed choice through appropriate referral. (Health Policy 15 Nov 2018).
- Feng Y, Flitcroft K, van Leeuwen MT, Elshaug AG, Spillane A, Pearson S-A. Patterns of immediate breast reconstruction in New South Wales, Australia: A population-based study (ANZJS Dec 2018).
- Flitcroft K, Brennan M, Spillane A. Breast reconstruction in metropolitan and regional areas of Australia: Principles of patient-centred care as best practice. (Supportive Care in Cancer, 21 Dec 2018).
- Spillane A, Flitcroft K, Warrier S, Katelaris A. Evaluation of a structured clinical program and formal coursework in breast surgeon training in Australia and New Zealand. (Eur J Surg Oncol, 8 Feb 2019)
- Health system barriers to the provision of breast reconstruction options in Australia: Improving informed choice through appropriate referral. Melbourne International Joint Breast Congress, Melbourne (11-13 October 2018)
- Legitimacy of Population Screening: Challenges from Cancer Screening Programs in Australia. 50 Years of Wilson and Jungner Workshop [Invited Speaker] London (June 18-19 2018).
- Documenting health service inequities and identifying potential criteria for addressing them: A case study of breast reconstruction in Australia. Clinical Oncology Society of Australia. Cancer Survivorship Conference, Adelaide (2-3 February 2017).
- Equity implications of uncoordinated health data collection systems: The case of breast reconstruction in Australia. Sydney Cancer Conference, Sydney (22 September 2016).
- The importance of choice: A prospective evaluation of factors affecting preference for immediate, delayed or no breast reconstruction in the context of mastectomy and post-mastectomy radiotherapy for breast cancer. Association of Breast Surgery Conference, Bournemouth, England (15 June 2015).
- An institutional approach to knowledge utilisation: Policy lessons from bowel cancer screening in three nations. Population Health Congress 2012. Adelaide Convention Centre (10-12 September 2012)
- A comparative analysis of bowel cancer screening policy in Australia, New Zealand and the UK: evidence lost in translation? Sydney Health Policy Network Symposium. University of Sydney (16 May 2011)
- The role of deliberative strategies in getting evidence into policy. Emerging Health Policy Research Conference, University of Sydney (11 August 2010)
- A test case of research utilisation by policy makers. Emerging Health Policy Research Conference, University of Sydney (19 August 2009)
- How important is evidence in policy decisions about cancer screening programs? Emerging Health Policy Research Conference, Australian National University, Canberra (12 October 2007)
- The impact of lack of choice of breast reconstruction options on Australian women’s quality of life. COSA, Cancer Survivorship Conference, Sydney (28-29 March 2019).
- Why aren't women in 30% of Australia’s capital city hospitals having breast reconstruction following mastectomy for breast cancer? The role of the surgeon. Association of Breast Surgery Conference, Belfast, Northern Ireland (15-16 May 2017).
- Breast reconstruction in Australia: Documenting the evidence on access. Controversies in Breast Cancer Congress, Melbourne (20-21 October 2015).